Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Assembly Biosciences (ASMB) over the last 5 years, with Sep 2025 value amounting to $12.7 million.

  • Assembly Biosciences' Shares Outstanding (Diluted Average) rose 99.74% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 99.74%. This contributed to the annual value of $6.0 million for FY2024, which is 31.18% up from last year.
  • According to the latest figures from Q3 2025, Assembly Biosciences' Shares Outstanding (Diluted Average) is $12.7 million, which was up 65.70% from $7.7 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Shares Outstanding (Diluted Average) peaked at $48.4 million during Q3 2022, and registered a low of $4.0 million during Q4 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $5.6 million (2024), whereas its average is $6.3 million.
  • As far as peak fluctuations go, Assembly Biosciences' Shares Outstanding (Diluted Average) slumped by 91.17% in 2023, and later soared by 99.74% in 2025.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Shares Outstanding (Diluted Average) stood at $43.3 million in 2021, then crashed by 90.68% to $4.0 million in 2022, then rose by 13.47% to $4.6 million in 2023, then skyrocketed by 31.18% to $6.0 million in 2024, then spiked by 99.74% to $12.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $12.7 million in Q3 2025, compared to $7.7 million in Q2 2025 and $7.5 million in Q1 2025.